IP Verse

Virion-Like Delivery Particles For Self-Replicating Rna Molecules

Patent No. EP4005592 (titled "Virion-Like Delivery Particles For Self-Replicating Rna Molecules") was filed by Glaxosmithkline on Jul 6, 2011. The application was issued on Oct 12, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONJul 12, 2023MEWBURN ELLIS
THOMANNJul 11, 2023THOMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4005592

GLAXOSMITHKLINE
Application Number
EP21204155A
Filing Date
Jul 6, 2011
Status
Granted And Under Opposition
Sep 9, 2022
Publication Date
Oct 12, 2022
External Links
Slate, Register , Google Patents